Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us 
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us 
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Tides Asia
Not Confirmed
Contact SupplierTides Asia
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11610
Submission : 1995-07-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24763
Submission : 2011-03-15
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
CEP/COS
Certificate Numbers : R1-CEP 2004-180 - Rev 00
Status : Valid
Issue Date : 2010-06-25
Type : Chemical
Substance Number : 1247
CEP/COS
Certificate Numbers : R1-CEP 2010-154 - Rev 03
Status : Valid
Issue Date : 2022-05-12
Type : Chemical
Substance Number : 416
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
Details:
Nitric Oxide is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Pulmonary Atelectasis.
Lead Product(s): Nitric Oxide,Inapplicable
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Miscellaneous
Sponsor: Fernando Suarez Sipmann
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 24, 2023
Lead Product(s) : Nitric Oxide,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Fernando Suarez Sipmann
Deal Size : Inapplicable
Deal Type : Inapplicable
Role of Inhaled Nitric Oxide in Vascular Mechanics and Right Ventricular Function
Details : Nitric Oxide is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Pulmonary Atelectasis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 24, 2023
Details:
EMONO is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neuralgia.
Lead Product(s): EMONO,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Undisclosed
Sponsor: AMS Advanced Medical Services
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 08, 2016
EMONO for the Treatment of Peripheral Neuropathic Pain
Details : EMONO is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neuralgia.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 08, 2016
Details:
Nitrous Oxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hyperalgesia.
Lead Product(s): Nitrous Oxide,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: ORION Clinical Services
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 20, 2012
Lead Product(s) : Nitrous Oxide,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : ORION Clinical Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Nitrous Oxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hyperalgesia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 20, 2012
Details:
Helium is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.
Lead Product(s): Helium,Oxygen
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Asklepios Kliniken Hamburg
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 18, 2011
Lead Product(s) : Helium,Oxygen
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Asklepios Kliniken Hamburg
Deal Size : Inapplicable
Deal Type : Inapplicable
Six-Minute Walk Test Comparing Helium/Oxygen to Nitrogen/Oxygen for COPD Rehabilitation
Details : Helium is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 18, 2011
Details:
Xenon is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Coronary Artery Disease.
Lead Product(s): Xenon,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Orion Corporation
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 11, 2011
Lead Product(s) : Xenon,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Orion Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Xenon is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Coronary Artery Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 11, 2011
Details:
Xenon is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Delirium.
Lead Product(s): Xenon,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: OptumInsight
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 10, 2010
Hip Fracture Surgery in Elderly Patients
Details : Xenon is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Delirium.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 10, 2010
Details:
Helium is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.
Lead Product(s): Helium,Oxygen
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 01, 2010
Lead Product(s) : Helium,Oxygen
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Helium is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 01, 2010
Details:
Xenon is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Coronary Artery Disease.
Lead Product(s): Xenon,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Eurofins Biomnis | Monitoring Force Group | Inferential
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 11, 2010
Lead Product(s) : Xenon,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Eurofins Biomnis | Monitoring Force Group | Inferential
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Xenon is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Coronary Artery Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 11, 2010
Details:
Xenon is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Xenon,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 06, 2010
Lead Product(s) : Xenon,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Sympathetic Neural Outflow During Xenon Anesthesia in Humans
Details : Xenon is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 06, 2010
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
Inspections and registrations
ABOUT THIS PAGE
Air Liquide Group is a supplier offers 4 products (APIs, Excipients or Intermediates).
Find a price of Nitric Oxide bulk with DMF offered by Air Liquide Group
Find a price of Nitrogen bulk with CEP offered by Air Liquide Group
Find a price of Nitrous Oxide bulk with CEP offered by Air Liquide Group
Find a price of Nitric Oxide bulk offered by Air Liquide Group
